What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Dopamine
- Organic chemistry
The scientist’s investigation covers issues in Dopamine, Methylphenidate, Raclopride, Dopamine receptor D2 and Striatum.
Endocrinology, Internal medicine and Neuroscience are the subject areas of his Dopamine study.
The Methylphenidate study combines topics in areas such as Anesthesia, Pharmacology and Brain mapping.
His biological study spans a wide range of topics, including Volume of distribution, Microdialysis, Reuptake inhibitor and Binding potential.
His work deals with themes such as Dopamine receptor and Nisoxetine, which intersect with Dopamine receptor D2.
He usually deals with Striatum and limits it to topics linked to Putamen and Methamphetamine.
His most cited work include:
- Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data (1245 citations)
- Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers (781 citations)
- Dopamine Transporter Occupancies in the Human Brain Induced by Therapeutic Doses of Oral Methylphenidate (773 citations)
What are the main themes of his work throughout his whole career to date?
Yu-Shin Ding mostly deals with Pharmacology, Dopamine, Endocrinology, Internal medicine and Positron emission tomography.
His research in Pharmacology intersects with topics in Central nervous system, Nicotinic agonist and Human brain.
Dopamine is frequently linked to Methylphenidate in his study.
His research integrates issues of Anesthesia and Addiction in his study of Methylphenidate.
His Endocrinology study frequently draws connections to other fields, such as Free fraction.
His biological study deals with issues like Putamen, which deal with fields such as Substantia nigra and Binding potential.
He most often published in these fields:
- Pharmacology (31.89%)
- Dopamine (28.11%)
- Endocrinology (29.19%)
What were the highlights of his more recent work (between 2009-2015)?
- Endocrinology (29.19%)
- Internal medicine (29.19%)
- Nuclear medicine (12.43%)
In recent papers he was focusing on the following fields of study:
Yu-Shin Ding focuses on Endocrinology, Internal medicine, Nuclear medicine, Positron emission tomography and Binding potential.
His Endocrinology research incorporates elements of Tourette syndrome and Serotonin.
His study on Internal medicine is mostly dedicated to connecting different topics, such as Clinical psychology.
His Nuclear medicine study also includes fields such as
- Bolus, which have a strong connection to Scan time and Temporal cortex,
- Substantia nigra together with Thalamus, Ventral striatum and Dopamine receptor D2.
Yu-Shin Ding has researched Binding potential in several fields, including Volume of distribution, Putamen and Pathology.
His Haloperidol study is focused on Dopamine in general.
Between 2009 and 2015, his most popular works were:
- Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo. (173 citations)
- Histidine Decarboxylase Deficiency Causes Tourette Syndrome: Parallel Findings in Humans and Mice (149 citations)
- Endotoxin-induced systemic inflammation activates microglia: [11C]PBR28 positron emission tomography in nonhuman primates (145 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Organic chemistry
- Dopamine
Internal medicine, Endocrinology, Positron emission tomography, Free fraction and Nuclear medicine are his primary areas of study.
His Internal medicine research is multidisciplinary, relying on both Standardized uptake value and Clinical psychology.
His study in Endocrinology is interdisciplinary in nature, drawing from both Inflammation and Comorbidity.
His Positron emission tomography study incorporates themes from Cerebellum and Radioligand.
His Free fraction research is multidisciplinary, incorporating perspectives in Atomoxetine, Norepinephrine Plasma Membrane Transport Proteins and Putamen.
He works mostly in the field of Atomoxetine, limiting it down to topics relating to Norepinephrine transporter and, in certain cases, Dopamine transporter, Attention deficit hyperactivity disorder, Maintenance dose, Methylphenidate and Catecholamine, as a part of the same area of interest.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
